immune-response

Documents about immune-response

• Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity#885377ClinicalTrials.gov
• Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis#913651ClinicalTrials.gov
• Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort#1046505ClinicalTrials.gov
• Behavioral Inhibition in Rhesus Monkeys (Macaca mulatta) Is Related to the Airways Response, but Not Immune Measures, Commonly Associated with Asthma#612107eScholarship
• Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform#121327ClinicalTrials.gov
• Live attenuated Mycobacterium bovis strains combined with the encapsulated H65 antigen as a vaccine strategy against bovine tuberculosis in a mouse model#196576DSpace
• RNAs Associated With Bacterial Outer Membrane Vesicles: Structural Insights Into Surface Composition#274328HAL (France)
• Whole-genome sequencing reveals divergent and shared selection signatures of heat stress adaptation in indigenous Ethiopian zebu cattle from dry-hot and humid-hot environments#646436PLOS
• Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women#803842ClinicalTrials.gov
• A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults#811715ClinicalTrials.gov
• Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults#852421ClinicalTrials.gov
• Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings#890359ClinicalTrials.gov
• Long-Term Lamivudine Therapy for Chronic Hepatitis B#992464ClinicalTrials.gov
• Experimental data on infection dynamics of Trypanosoma cruzi Dm28c in BALB/c mice: parasitemia, splenic immune response, and cardiac histology#406622RDA UNR Dataverse OAI Archive
• Modulation of the response to immunotherapy in triple-negative breast cancer: the role of the microbiota and microbial metabolites in the tumor microenvironment#642682Europe PMC
• A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine#143646ClinicalTrials.gov
• Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults#623543ClinicalTrials.gov
• A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.#633746ClinicalTrials.gov
• Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons#826321ClinicalTrials.gov
• Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants#882463ClinicalTrials.gov
• Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine#912660ClinicalTrials.gov
• ALTERNATIVELY SPLICED ISOFORMS OF IRF7 DIFFERENTIALLY REGULATE INNATE IMMUNE SIGNALING TO TUNE CELLULAR RESPONSE TO VIRAL INFECTION#929265ScholarlyCommons
• A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy#414352ClinicalTrials.gov
• Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer#467615ClinicalTrials.gov
• A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.#839717ClinicalTrials.gov
• Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection#842247ClinicalTrials.gov
• Use of luminescent proximity-based techniques to investigate IL-23 receptor complex formation, cytokine binding and activation in living cells#1041717University of Nottingham Repository
• Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults#279567ClinicalTrials.gov
• Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response#892549ClinicalTrials.gov
• Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection#903432ClinicalTrials.gov
• Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells#982057ClinicalTrials.gov
• Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma#208278ClinicalTrials.gov
• Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda#405205ClinicalTrials.gov
• Caractérisation du rôle de la voie IRE1/XBP1 de la réponse UPR dans le processus de maturation immunogénique et les fonctions des cDC1 spléniques lors de l'infection à Toxoplasma gondii#643299HAL (France)
• Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine#868312ClinicalTrials.gov
• Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People#1045666ClinicalTrials.gov
• Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa#197685SUNScholar
• The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response#811978ClinicalTrials.gov
• Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine#869487ClinicalTrials.gov
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth#903226ClinicalTrials.gov
• A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age#918725ClinicalTrials.gov
• Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults#871319ClinicalTrials.gov
• Dataset: Data corresponding to the study of the nuclear receptors nr4a participation in the immune-endocrine response during tuberculosis#406591RDA UNR Dataverse OAI Archive
• Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older#880370ClinicalTrials.gov
• Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects#1046316ClinicalTrials.gov
• Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients#810970ClinicalTrials.gov
• Deciphering the Renal tumOr microenvironment to PersonaLize immunE-targeted Treatment (DROPLET): transcriptomic profiling of primary and secondary lesions identified a potential crosstalk between MARCO+ macrophages and deregulated cancer-cell proliferation in mediating progression and therapy response of advanced renal cell carcinoта.#823162IRIS
• A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes#879985ClinicalTrials.gov
• A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.#28417ClinicalTrials.gov
• Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)#852205ClinicalTrials.gov